Evidence map›Paper›PMID 40115864›Full record

ArticleClinical nephrology. Case studies2025

A case report of renal oxalosis and secondary hyperoxaluria due to chronic high vitamin C consumption.

Ioannis Eleftherios Neofytou, Georgios Lioulios, Emmanouil Almaliotis, Dimitra Vasilia Daikidou, Aikaterini Mplatsa, Elias Minasidis

Abstract readCase Reports
In one paragraph

Article in Clinical nephrology. Case studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ioannis Eleftherios NeofytouNephrology Department, 424 General Military Hospital of Thessaloniki, Thessaloniki, Central Macedonia, Greece.
Georgios LiouliosNephrology Department, 424 General Military Hospital of Thessaloniki, Thessaloniki, Central Macedonia, Greece.
Emmanouil AlmaliotisNephrology Department, 424 General Military Hospital of Thessaloniki, Thessaloniki, Central Macedonia, Greece.
Dimitra Vasilia DaikidouNephrology Department, 424 General Military Hospital of Thessaloniki, Thessaloniki, Central Macedonia, Greece.
Aikaterini MplatsaNephrology Department, 424 General Military Hospital of Thessaloniki, Thessaloniki, Central Macedonia, Greece.
Elias MinasidisNephrology Department, 424 General Military Hospital of Thessaloniki, Thessaloniki, Central Macedonia, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal oxalosis occurs from supersaturation of the urine with oxalate in the presence of calcium, resulting in deposition of calcium oxalate crystals within renal tissue and, consequently, progressive renal disease. One of the causes of secondary hyperoxaluria is a high intake of vitamin C, which exceeds the renal excretion capacity, and can induce renal oxalosis. We present a case involving a 67-year-old patient with chronic kidney disease and proteinuria, associated with secondary hyperoxaluria and renal oxalosis, who reported prolonged, excessive intake of vitamin C supplements. The patient presented with a gradual worsening of his renal function and proteinuria during the last 6-month period, after an episode of SARS-CoV-2 infection. The kidney biopsy revealed calcium oxalate crystals within the renal tissue. Thorough investigation and history-taking revealed a substantial increase in vitamin C supplementation during the SARS-CoV-2 infection (up to 3 g daily), indicating secondary hyperoxaluria as the causative factor. Overall during the pandemic, supplement consumption dramatically increased and patients were not adequately informed about the risks of various over-the-counter products. Excessive intake of vitamin C, popularized for its supposed health benefits, can lead, among others, to secondary hyperoxaluria and renal oxalosis. Prompt recognition is pivotal to initiate management and to prevent irreversible kidney damage.

Indexed as

calcium oxalate crystalschronic kidney diseaserenal oxalosissecondary hyperoxaluriavitamin C

Identifiers

PMID40115864
PMCPMC11924107

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.